ReviewArchives of gynecology and obstetrics2020
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
Daniel Martin Klotz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papertrialcites it